Jean‐Loup Demory

1.0k total citations
14 papers, 641 citations indexed

About

Jean‐Loup Demory is a scholar working on Genetics, Hematology and Rheumatology. According to data from OpenAlex, Jean‐Loup Demory has authored 14 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 12 papers in Hematology and 5 papers in Rheumatology. Recurrent topics in Jean‐Loup Demory's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Acute Myeloid Leukemia Research (6 papers). Jean‐Loup Demory is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Acute Myeloid Leukemia Research (6 papers). Jean‐Loup Demory collaborates with scholars based in France, Italy and Spain. Jean‐Loup Demory's co-authors include F Bauters, Jean-Luc Laı̈, Brigitte Dupriez, Claude Preudhomme, Eric Wattel, Pierre Fenaux, Dominique Bordessoule, Yvon Sterkers, John T. Reilly and Francisco Cervantes and has published in prestigious journals such as Blood, British Journal of Haematology and Genes Chromosomes and Cancer.

In The Last Decade

Jean‐Loup Demory

12 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jean‐Loup Demory France	8	570	491	269	175	14	14	641
Giacomo Coltro Italy	12	501 0.9×	440 0.9×	275 1.0×	181 1.0×	17 1.2×	32	563
Jacob Grinfeld United Kingdom	11	277 0.5×	228 0.5×	177 0.7×	112 0.6×	28 2.0×	19	365
Rangit Vallapureddy United States	10	352 0.6×	313 0.6×	219 0.8×	102 0.6×	6 0.4×	16	446
Shireen Sirhan Canada	14	557 1.0×	384 0.8×	331 1.2×	250 1.4×	37 2.6×	35	594
Guntram Buesche Germany	12	390 0.7×	396 0.8×	170 0.6×	149 0.9×	28 2.0×	20	513
Marta Sobas Poland	7	388 0.7×	271 0.6×	255 0.9×	146 0.8×	54 3.9×	32	440
Shiqiang Qu China	12	211 0.4×	295 0.6×	116 0.4×	71 0.4×	28 2.0×	45	365
Carme Talarn Spain	8	129 0.2×	206 0.4×	104 0.4×	42 0.2×	22 1.6×	13	293
Fabrizio Ciccone Italy	8	403 0.7×	460 0.9×	57 0.2×	208 1.2×	81 5.8×	13	574
Ravin J. Garg United States	9	200 0.4×	217 0.4×	82 0.3×	82 0.5×	56 4.0×	11	367

Countries citing papers authored by Jean‐Loup Demory

Since Specialization

Citations

This map shows the geographic impact of Jean‐Loup Demory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Loup Demory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Loup Demory more than expected).

Fields of papers citing papers by Jean‐Loup Demory

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Loup Demory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Loup Demory. The network helps show where Jean‐Loup Demory may publish in the future.

Co-authorship network of co-authors of Jean‐Loup Demory

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Loup Demory. A scholar is included among the top collaborators of Jean‐Loup Demory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Loup Demory. Jean‐Loup Demory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Charpentier, Agnès, Nathalie Cambier, Anne Bauters, et al.. (2014). Procoagulant Platelet-Derived Microparticles Are Lower in Calreticulin-Than in-JAK2-Mutated Essential Thrombocythemia. Blood. 124(21). 110–110. 1 indexed citations

2.

Ianotto, Jean‐Christophe, Emmanuel Gyan, Kamel Laribi, et al.. (2013). Efficacy and safety of pegylated‐interferon α‐2a in myelofibrosis: a study by the FIM and GEM French cooperative groups. British Journal of Haematology. 162(6). 783–791. 57 indexed citations

3.

Demory, Jean‐Loup, et al.. (2013). High Prevalence Of Aspirin-Resistance In Myeloproliferative Neoplasms. Blood. 122(21). 5250–5250.

4.

Ianotto, Jean‐Christophe, Jean‐Loup Demory, Jérôme Rey, et al.. (2010). Efficacy and Safety of Peg-Interferon-α2a In Myelofibrosis: a Study of the FIM and GEM French Cooperative Groups. Blood. 116(21). 4103–4103. 3 indexed citations

5.

Morel, Pierre, et al.. (2010). Identification during the follow-up of time-dependent prognostic factors for the competing risks of death and blast phase in primary myelofibrosis: a study of 172 patients. Blood. 115(22). 4350–4355. 29 indexed citations

6.

Cervantes, Francisco, Brigitte Dupriez, Arturo Pereira, et al.. (2008). A New Prognostic Scoring System for Primary Myelofibrosis Based on a Study of the International Working Group for Myelofibrosis Research and Treatment. Blood. 112(11). 657–657. 62 indexed citations

7.

Andrieux, Joris, Catherine Roche‐Lestienne, Sandrine Geffroy, et al.. (2007). Bone morphogenetic protein antagonist gene NOG is involved in myeloproliferative disease associated with myelofibrosis. Cancer Genetics and Cytogenetics. 178(1). 11–16. 8 indexed citations

8.

Roche‐Lestienne, Catherine, Agnès Charpentier, Sandrine Geffroy, et al.. (2007). CASE REPORTS in HAEMATOLOGY (Paper co-edited with the European LeukemiaNet) Isolated trisomy 2 is non-random and may be found in myelodysplastic syndrome and in acute myeloblastic leukaemia. Case 1.

9.

Dupriez, Brigitte & Jean‐Loup Demory. (2005). [Myelofibrosis with myeloid metaplasia: diagnosis and treatment].. PubMed. 55(15). 1680–5. 1 indexed citations

10.

Andrieux, Joris, Jean‐Loup Demory, Brigitte Dupriez, et al.. (2003). Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia. Genes Chromosomes and Cancer. 39(1). 82–87. 39 indexed citations

11.

Dupriez, Brigitte & Jean‐Loup Demory. (2002). La splénomégalie myéloïdeMise à jour des critères diagnostiques, des facteurs pronostiques et du traitement. Hématologie. 8(3). 197–203. 1 indexed citations

12.

Cervantes, Francisco, Giovanni Barosi, Jean‐Loup Demory, et al.. (1998). Myelofibrosis with myeloid metaplasia in young indidviduals: disease characteristics, prognostic factors and identification of risk groups. British Journal of Haematology. 102(3). 684–690. 132 indexed citations

13.

Sterkers, Yvon, Claude Preudhomme, Jean-Luc Laı̈, et al.. (1998). Acute Myeloid Leukemia and Myelodysplastic Syndromes Following Essential Thrombocythemia Treated With Hydroxyurea: High Proportion of Cases With 17p Deletion. Blood. 91(2). 616–622. 13 indexed citations

14.

Sterkers, Yvon, Claude Preudhomme, Jean-Luc Laı̈, et al.. (1998). Acute Myeloid Leukemia and Myelodysplastic Syndromes Following Essential Thrombocythemia Treated With Hydroxyurea: High Proportion of Cases With 17p Deletion. Blood. 91(2). 616–622. 295 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact